Skip to main content

ENVERIC BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Enveric Biosciences, Inc. - ENVB

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of MagicMed Industries Inc. to Enveric Biosciences, Inc. (“the Company”) (NasdaqCM: ENVB). Under the terms of the proposed transaction, current Enveric shareholders will own only approximately 63.4% of the combined company's common stock. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders.

If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-envb/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.50
+0.00 (0.00%)
AAPL  266.43
+0.00 (0.00%)
AMD  258.12
+0.00 (0.00%)
BAC  54.32
+0.00 (0.00%)
GOOG  334.47
+0.00 (0.00%)
META  671.58
+0.00 (0.00%)
MSFT  411.22
+0.00 (0.00%)
NVDA  198.86
+0.00 (0.00%)
ORCL  169.81
+0.00 (0.00%)
TSLA  391.95
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.